Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XF8W
|
||||
Former ID |
DAP000660
|
||||
Drug Name |
Pyrazinamide
|
||||
Synonyms |
Aldinamid; Aldinamide; Braccopiral; Corsazinmid; Dipimide; Eprazin; Farmizina; Isopas; Lynamide; Novamid; PZA; Pezetamid; Pharozinamide; Piraldina; Pirazimida; Pirazinamid; Pirazinamida; Pirazinamide; Prazina; Pyrafat; Pyramide; Pyrazide; Pyrazinamdie; Pyrazinamidum; Pyrazineamide; Pyrazinecarboxamide; Rozide; Tebrazid; Tebrazio; Tisamid; Unipyranamide; Zinamide; Zinastat; P ezetamid; Pirazinamide [DCIT]; Pyrazine carboxamide; Pyrazine carboxylamide; Pyrazinecarboxylic acid amide; Pyrazinoic acid am ide; Pyrazinoic acid amide; DRG 0124; MK 56; P 7136; Pyrazinamide BP 2000; T 165; AZT + Pyrazinamide combination; D-50; Pirazinamida [INN-Spanish]; Pms-Pyrazinamide; Pyrazinamide (TN); Pyrazinamidum [INN-Latin]; D-50 (VAN); Pyrazinamide [INN:BAN:JAN]; Pyrazine-2-carboxamide; Pyrazinamide (JP15/USP/INN); Pyrazinoic acid amide, Pezetamid, Pyrafat, Zinamide, Tebrazid, Pyrafat, Pyrazinamide; 2-Carbamylpyrazine; 2-Pyrazinecarboxamide; 2-carbamyl pyrazine
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Antitubercular Agents
|
||||
Structure |
Download2D MOL |
||||
Formula |
C5H5N3O
|
||||
InChI |
InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)
|
||||
InChIKey |
IPEHBUMCGVEMRF-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 98-96-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
3115, 5057, 78938, 602930, 866420, 3135875, 7437580, 7847212, 7980439, 8002616, 8139959, 8149510, 10321757, 10539072, 11111657, 11111658, 11335416, 11360655, 11363796, 11366358, 11368920, 11371892, 11374989, 11377082, 11461627, 11466542, 11467662, 11485105, 11486124, 11489121, 11490861, 11493000, 11494716, 15119868, 16957225, 17389747, 17405569, 24278648, 24439399, 24887930, 25623302, 26611902, 26679227, 26697102, 26747228, 26747229, 26752748, 39214717, 46507478, 47810638
|
||||
ChEBI ID |
ChEBI:45285
|
||||
SuperDrug ATC ID |
J04AK01
|
||||
SuperDrug CAS ID |
cas=000098964
|
||||
Drug Resistance Mutation (DRM) | |||||
DRM | DRM Info | ||||
Target and Pathway | |||||
Target(s) | Enoyl-[acyl-carrier-protein] reductase [NADH] | Target Info | Inhibitor | [535045] | |
References | |||||
Ref 536472 | Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8. | ||||
Ref 542307 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7287). | ||||
Ref 551871 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.